GENEVA, Oct. 28 -- MAZE THERAPEUTICS, INC. (171 Oyster Point Blvd., Suite 300South San Francisco, California 94080) filed a patent application (PCT/US2025/024589) for "APOL1 INHIBITORS AND METHODS OF USE THEREOF" on Apr 14, 2025. With publication no. WO/2025/221691, the details related to the patent application was published on Oct 23, 2025.
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Inventor(s): BRONNER, Sarah M. (c/o Maze Therapeutics, Inc.171 Oyster Point Blvd., Suite 300South San Francisco, California 94080), ZHANG, Birong (c/o Maze Therapeutics, Inc.171 Oyster Point Blvd., Suite 300South San Francisc...